Quarterly report pursuant to Section 13 or 15(d)

Fair Value of Financial Instruments - Narrative (Details)

v3.22.2.2
Fair Value of Financial Instruments - Narrative (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Nov. 14, 2022
Sep. 30, 2022
Jun. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2019
Dec. 31, 2021
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]                
Reclassifications from other comprehensive loss   $ 100,000     $ 100,000      
Reclassification adjustment for gain included in net loss     $ 332,000 $ 0 332,000 $ 0    
Equity investments without readily determinable fair value   $ 2,500,000     $ 2,500,000     $ 2,500,000
Equity method investments, upward price adjustment             $ 1,500,000  
Subsequent Event                
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]                
Proceeds from sale of equity securities $ 700,000